Table of contents

• What Is Ovarian Cancer Screening?
• Best Clinics in Korea for Ovarian Cancer Screening
• Getting Ovarian Cancer Screening in Korea
• Cost of Ovarian Cancer Screening in Korea
• Alternatives to Ovarian Cancer Screening
• Conclusion

Considering treatment in Korea? Everything you need to know e.g. — how to avoid scams, visas, interpreters, recovery tips — in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!

---

Could the key to combating ovarian cancer, known as the 'silent killer,' lie within the intricacies of the Korean healthcare system? This article uncovers the nuanced world of ovarian cancer screening in Korea, highlighting cutting-edge diagnostic procedures and examining how access to these vital services can make a life-saving difference for women.

What Is Ovarian Cancer Screening?

Ovarian cancer screening refers to the medical process aimed at detecting ovarian cancer in its early stages in women who do not yet show any symptoms. The rationale behind this screening procedure is that early detection could potentially lead to more effective treatment and a higher survival rate. However, ovarian cancer screening is complex due to the deep location of the ovaries, which makes it challenging to detect abnormalities without advanced methods.

Key Screening Methods

The primary methods employed for ovarian cancer screening include:

• Transvaginal Ultrasound (TVUS): This is a type of imaging test where a small probe is inserted into the vagina to closely visualize the ovaries and check for abnormalities such as tumors or cysts. TVUS is non-invasive and relatively straightforward but may not distinguish between cancerous and non-cancerous conditions.

• CA-125 Blood Test: This test measures the level of CA-125, a protein often found in higher quantities in women with ovarian cancer. However, CA-125 is not exclusively indicative of ovarian cancer, as elevated levels can also be present in other conditions such as endometriosis and pelvic inflammatory disease, leading to potential false positives.

Limitations and Considerations

Despite the availability of these tests, ovarian cancer screening is not universally recommended for the general population due to several limitations:

• False Positives and False Negatives: Both TVUS and CA-125 tests can produce false positives, causing unnecessary stress and additional invasive procedures, or false negatives, giving a misleading sense of security.

• Lack of Efficacy in Mortality Reduction: Currently, no solid evidence supports that screening with these tests significantly decreases mortality rates from ovarian cancer.

• Selection Criteria: Screening is generally more beneficial in women who are at high risk, such as those with a family history of ovarian or breast cancer, or genetic mutations like BRCA1 and BRCA2. For these individuals, a tailored approach is often advised.

Ongoing Research

Research continues into more reliable and sensitive screening techniques. Advances in genomics and biotechnology are paving the way for potential new biomarkers and imaging techniques that could improve the accuracy and efficacy of ovarian cancer screening.

Thus, ovarian cancer screening remains an area of active investigation with the hope of achieving a reliable early detection strategy in the future.

Best Clinics in Korea for Ovarian Cancer Screening

Listed below are the best clinics in Korea for ovarian cancer screening:

Clinic Name	Key Features	Special Techniques
SH Clinic	Specialized women’s medical center uniting stem-cell science and comprehensive gynecologic care; personalized care via SH Stem Cell Center and SH Gynecology Clinic (regenerative therapies to full-spectrum services and cancer screening); all screenings/procedures/surgeries performed by a highly experienced, board-certified gynecologist (Minister of Health and Welfare commendation); dedicated women’s care setting prioritizing comfort, privacy, and clear communication; individualized, protocol-driven care with clear results explanation, personalized risk assessment, and tailored follow-up; seamless continuity within the same center minimizing unnecessary referrals/delays; centrally located in Sinsa, Seoul with coordinated, privacy-respecting scheduling.	Pelvic/transvaginal ultrasound for ovarian health assessment; cervical screening with Pap and HPV testing.
Cheongdam HIFU Clinic	One‑stop gynecologic care integrating expert evaluation with non‑surgical, minimally invasive, and advanced surgical options; experienced team leveraging state‑of‑the‑art technology to characterize ovarian findings; dedicated Ovarian Cyst Sclerotherapy Clinic reducing unnecessary operations while prioritizing safety; personalized care plans, rapid care pathways, and comprehensive on‑site solutions with immediate, tailored follow‑up.	Laparoscopic surgery; Da Vinci robotic procedures; HIFU; targeted sclerotherapy; hysteroscopy.
Daegu Spring Women’s Clinic	Women’s Health Screening Center integrated with comprehensive gynecologic care and a patient‑centered philosophy; preventive framework spanning basic/detailed check‑ups, cervical cancer screening, menopause screening, and tailored “life‑moment” programs (e.g., wedding screening); General Gynecology Center expertise in menstrual disorders, abnormal uterine bleeding, and menopausal changes with prompt, thorough evaluation; coordinated, personalized pathways from screening through follow‑up; broad in‑house capabilities and seamless, confidential support in Dongseong‑ro, Daegu.	Diagnostics such as vaginal pressure measurement; women’s external surgery; laser and rejuvenation services; contraception, pregnancy care, and immunization.

SH Clinic

SH Clinic in Sinsa, Seoul is a specialized medical center that unites stem-cell science and comprehensive women’s healthcare under one roof. Through the SH Stem Cell Center and SH Gynecology Clinic, patients receive personalized care ranging from regenerative therapies to full-spectrum gynecologic services and cancer screening. All screenings, procedures, and surgeries are performed directly by our highly experienced, board-certified gynecologist—recognized with a commendation from the Minister of Health and Welfare—within a dedicated women’s care setting that prioritizes comfort, privacy, and clear communication.

• Board-certified, award-recognized expertise: our gynecologist personally conducts every screening and procedure, ensuring consistent, expert care.
• Specialized women’s clinic: a female-focused environment designed for comfort, discretion, and trust.
• Comprehensive approach to screening: ovarian health assessment with pelvic/transvaginal ultrasound, paired with cervical screening (Pap and HPV testing) for a thorough evaluation of reproductive health in one place.
• Individualized, protocol-driven care: clear explanation of results, personalized risk assessment, and tailored follow-up plans.
• Seamless continuity: from screening to office-based care and gynecologic procedures within the same center, minimizing unnecessary referrals and delays.
• Central convenience: located in Sinsa, Seoul, with coordinated scheduling that respects busy lives and privacy needs.

You can check out their website here: SH Clinic Website

Cheongdam HIFU Clinic

Cheongdam HIFU Clinic stands out as Korea’s best destination for ovarian cancer screening because it delivers true one‑stop gynecologic care—seamlessly integrating expert evaluation with the full spectrum of non‑surgical, minimally invasive, and advanced surgical options for ovarian and uterine conditions. Its experienced medical team leverages state‑of‑the‑art technology to accurately characterize ovarian findings and, when needed, provides timely, precise interventions ranging from laparoscopic surgery for suspicious masses to Da Vinci robotic procedures for complex cases, ensuring minimal incisions and faster recovery. The dedicated Ovarian Cyst Sclerotherapy Clinic reflects deep subspecialty expertise in distinguishing benign cysts from lesions that warrant closer surveillance or surgical assessment, reducing unnecessary operations while prioritizing safety. For conditions that can mimic ovarian cancer—such as endometriosis and adenomyosis—the clinic offers advanced non‑surgical treatments, including HIFU and targeted sclerotherapy, to clarify diagnoses and relieve symptoms without major surgery. Hysteroscopic capabilities further enable meticulous assessment of intrauterine pathology that may coexist with ovarian concerns. By combining personalized care plans with rapid care pathways and comprehensive on‑site solutions, Cheongdam HIFU Clinic provides thorough ovarian cancer screening backed by immediate, tailored follow‑up when it matters most.

Find more about this clinic here: Cheongdam HIFU Clinic Website

Daegu Spring Women's Clinic

Daegu Spring Women’s Clinic stands out as the best clinic for ovarian cancer screening in Korea because it integrates a dedicated Women’s Health Screening Center with comprehensive gynecologic care and a deeply patient-centered philosophy. Its preventive framework—spanning basic and detailed check-ups, cervical cancer screening, menopause screening, and tailored “life-moment” programs like wedding screening—promotes vigilant, stage-appropriate assessment of gynecologic health, while the General Gynecology Center’s expertise in menstrual disorders, abnormal uterine bleeding, and menopausal changes ensures that symptoms potentially related to ovarian conditions are evaluated promptly and thoroughly. Grounded in extensive clinical experience, continuous research, and a commitment to safe, effective care that honors every emotion and concern, the clinic delivers coordinated, personalized pathways from initial screening through follow-up. With broad in-house capabilities—from diagnostics like vaginal pressure measurement to evidence-based therapies across women’s external surgery, laser and rejuvenation services, contraception, pregnancy care, and immunization—patients receive seamless, confidential support in one trusted location in Dongseong-ro, Daegu. For clarity, comfort, and confidence in ovarian cancer screening, contact Spring Women’s Clinic at 053-716-7106.

Find more about this clinic here: Daegu Spring Women's Clinic Website

Getting Ovarian Cancer Screening in Korea

Ovarian cancer is a significant health concern that can be challenging to detect in its early stages due to subtle symptoms and the lack of routine screening tests. However, in Korea, advancements in medical technology and increasing awareness have paved the way for comprehensive ovarian cancer screening protocols aimed at early detection and improved patient outcomes.

The Need for Screening

Early detection of ovarian cancer is crucial, as it significantly improves the chances of successful treatment and survival. Unfortunately, ovarian cancer is often diagnosed at a late stage due to its vague symptoms, which include abdominal discomfort, bloating, and changes in appetite. Korea has been at the forefront of integrating advanced screening techniques to address this challenge, ensuring that women have access to the best possible care.

Screening Methods

Transvaginal Ultrasound (TVUS)

In Korea, one of the primary methods for ovarian cancer screening is the transvaginal ultrasound (TVUS). This procedure involves the use of sound waves to create detailed images of the ovaries and uterus. A small ultrasound probe is inserted into the vagina, which allows for a closer and more accurate assessment of the ovarian structures. TVUS is particularly useful for visualizing ovarian cysts or abnormalities that may indicate the presence of cancerous cells.

CA-125 Blood Test

Another commonly used screening method is the CA-125 blood test. CA-125 is a protein that is elevated in the blood of many women with ovarian cancer. In Korean medical practice, this test is often performed alongside a TVUS to provide a more comprehensive understanding of a patient's risk. It is important to note that while elevated CA-125 levels can indicate ovarian cancer, they can also be caused by other conditions such as endometriosis or pelvic inflammatory disease, which necessitates careful interpretation of results.

Risk-Reducing Genetic Testing

For women with a family history of ovarian cancer or related genetic factors, Korea offers genetic testing as part of the screening process. This involves testing for mutations in genes like BRCA1 and BRCA2, which are known to significantly increase the risk of developing ovarian cancer. Identifying these genetic predispositions can help in formulating a tailored screening and prevention strategy, which may include more frequent monitoring or preventive surgeries.

Advanced Imaging Techniques

In addition to traditional methods, some Korean hospitals have adopted advanced imaging techniques, such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans, especially in cases where initial screening yields ambiguous results. These imaging modalities provide detailed cross-sectional views of the ovaries and surrounding tissues, aiding in the precise identification of potential malignancies.

Healthcare Infrastructure and Accessibility

Korea's healthcare system is known for its efficiency and accessibility, with state-of-the-art facilities equipped to perform ovarian cancer screening. Women can access these services through public healthcare initiatives or private medical centers, providing flexibility and choice. The emphasis on health education and preventative care in Korea also plays a crucial role in encouraging women to undergo recommended screenings, thereby enhancing early detection rates.

Cultural and Societal Perspectives

In Korea, awareness about ovarian cancer and the importance of early screening has been steadily increasing. Government and non-profit organizations continuously work on campaigns to educate the public about ovarian cancer screening, emphasizing the importance of early detection and regular check-ups. Cultural stigmas surrounding gynecological exams are being tackled through public health education, encouraging more women to seek necessary screenings without hesitation.

Challenges and Developments

While Korea has made significant strides in ovarian cancer screening, challenges remain. The need for continuous research into more effective and less invasive screening tests is a priority. Korean medical institutions are not only focusing on current technologies but are also investing in research aimed at identifying novel biomarkers and innovative screening techniques to further enhance early detection efforts.

Who is Ovarian Cancer Screening for?

• Women with a Family History of Ovarian or Breast Cancer

  • Individuals with close relatives who have been diagnosed with ovarian or breast cancer may have an increased risk, particularly if multiple family members are affected or if a relative was diagnosed at a young age.

• Carriers of BRCA1 or BRCA2 Gene Mutations

  • Women who have inherited mutations in the BRCA1 or BRCA2 genes are at a higher risk for developing ovarian cancer. Genetic testing can identify these mutations and guide decisions on screening.

• Women with Lynch Syndrome

  • Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), increases the risk of several types of cancer, including ovarian cancer. Women with this syndrome can benefit from regular screenings.

• Postmenopausal Women

  • The risk of ovarian cancer increases with age, particularly after menopause. Screening may be recommended for postmenopausal women, especially those with additional risk factors.

• Women with a History of Breast, Uterine, or Colorectal Cancer

  • Individuals with a history of certain cancers may have an increased risk of ovarian cancer, and screening may be more strongly considered in these cases.

• Women with Endometriosis

  • Studies have shown that endometriosis may slightly increase the risk of ovarian cancer. Depending on the severity and presence of other risk factors, screening might be recommended.

• Women of Ashkenazi Jewish Descent

  • This group is known to have a higher prevalence of BRCA1 and BRCA2 gene mutations, elevating the risk of ovarian cancer.

• Individuals Experiencing Symptoms of Ovarian Cancer

  • For those experiencing persistent bloating, pelvic or abdominal pain, difficulty eating, or urinary symptoms, screening can be instrumental in early detection and treatment.

• Women with Elevated Cancer Antigen 125 (CA-125) Levels

  • Elevated CA-125 levels can be a marker of ovarian cancer, especially in postmenopausal women, which might indicate the need for further screening and investigation.

Cost of Ovarian Cancer Screening in Korea

Ovarian cancer screening is a critical health procedure that helps in the early detection and treatment of ovarian cancer. While not routinely recommended for all women, it can be vital for those at higher risk. The cost of ovarian cancer screening can vary widely, influenced by factors such as technology, healthcare infrastructure, and government healthcare policies.

In Korea, the cost of ovarian cancer screening is relatively affordable compared to some Western countries. The pricing can range from approximately 100,000 to 300,000 KRW ($85 to $255 USD). This covers various tests that might include pelvic examinations, transvaginal ultrasounds, and blood tests for CA-125 levels, among others. The wide price range reflects different healthcare facilities, with private hospitals often at the higher end of the spectrum.

When comparing this to the United States, the cost of similar screening procedures can range from $200 to $1,500 USD. This range significantly depends on factors such as the healthcare provider, location, insurance coverage, and the specific tests included. The price disparity between Korea and the USA can be attributed to the differing healthcare systems; South Korea has a universal healthcare system that generally provides more cost-effective services.

In other countries like the UK, where the National Health Service (NHS) predominantly covers healthcare, costs for screening might be lower for those within the system, though private healthcare costs can be comparable to those in Korea. Meanwhile, in Australia, costs can range between $150 and $600 AUD, similar to Korea's private healthcare costs but sometimes higher due to differences in the private sector pricing.

These comparisons highlight how accessible and affordable ovarian cancer screening is in Korea, especially under its national healthcare policy, making it one of the more financially feasible options for patients in need of early detection services. However, prices can fluctuate based on additional services, institution reputation, and location within each country.

Alternatives to Ovarian Cancer Screening

While ovarian cancer screening can be crucial for early detection, it's essential to consider other methods that may complement or serve as alternatives to traditional screening, especially in regions like Korea where awareness and medical practices continually advance. Below are three suitable alternatives that can aid in the early detection and prevention of ovarian cancer.

1. Genetic Testing

Genetic testing is a powerful tool that can identify women at an increased risk of ovarian cancer, particularly those with a family history of the disease. The test typically looks for mutations in genes such as BRCA1 and BRCA2, which are known to elevate the likelihood of developing ovarian cancer. In Korea, advancements in genetic research have made these tests more accessible and informative. By understanding a patient's genetic makeup, healthcare providers can devise personalized monitoring plans, potentially combining them with other preventive measures to manage risk effectively.

2. Pelvic Ultrasound

Pelvic ultrasound is a non-invasive imaging technique that provides visuals of the ovaries and surrounding structures. While it is not a definitive screening tool for ovarian cancer, it can be useful in detecting abnormalities or changes in ovarian size and shape. In Korea, where medical facilities are state-of-the-art, pelvic ultrasound serves as an invaluable diagnostic adjunct, especially when symptoms or family history suggest an elevated risk. It can be particularly beneficial for women who cannot undergo regular screening due to medical or personal reasons.

3. CA-125 Blood Test

The CA-125 blood test measures the level of the cancer antigen 125 in the blood, which can be elevated in women with ovarian cancer. Although it is not recommended as a standalone screening test due to its limitations and potential for false positives, it can be part of a broader diagnostic strategy. In Korea, the CA-125 test is often used in conjunction with other methods such as ultrasounds and pelvic exams, especially for women showing early signs of ovarian issues or those with a notable genetic predisposition. This combined approach enhances the potential of early detection, allowing for more timely interventions.

These alternatives, when integrated into a comprehensive health monitoring strategy, can provide crucial insights and aid in the early detection of ovarian cancer, enhancing the chances of successful treatment and outcomes.

Conclusion

In conclusion, ovarian cancer screening in Korea provides an essential preventive measure, particularly for those in high-risk groups. With a well-developed healthcare infrastructure, Korea ensures that screening is more accessible to women, although it is primarily recommended for individuals with significant risk factors, such as a family history or genetic predispositions. The cost of ovarian cancer screening in Korea varies, but government initiatives and health insurance plans make it reasonably affordable for most citizens. While direct screening for ovarian cancer may not be universally recommended for all women due to potential risks and the complexity of interpretation, alternatives such as regular pelvic exams and awareness of early symptoms play a crucial role in early detection efforts. Overall, a balanced approach that combines screening with preventative and alternative measures can lead to better health outcomes in the fight against ovarian cancer.